Binitio Biomedical’s Exia 160 and Exia 160XL now Available Through MediLumine

One challenge for development of non toxic micro-CT contrast agents is to load a high concentration of an X-ray attenuating element in a nanoparticulate formulation with particle size distribution small enough to avoid accumulation in lungs but large enough to avoid kidney filtration.  Binitio Biomedical’s Exia 160 and Exia 160XL meet these requirements with sufficient stealth properties for vascular imaging. In addition, they are made of components which are metabolized by catabolic pathways in the body thus enabling metabolic imaging of the myocardium and brown adipose tissue.

Share This Post

More To Explore

Come Visit Us at WMIC 2022 in Miami

We are looking forward to this year’s WMIC conference in Miami! Come meet Stephen Marchant (CEO MediLumine Inc.) and Felix Gremse (CEO Gremse-IT) at Booth

New Fenestra HDVC Publication

Fenestra HDVC is a non-toxic contrast agent for small animal in vivo microCT imaging.  Micro-computed tomography (micro-CT) imaging has been used to analyze organs in

Managed by Carbon Digital